A subscription to JoVE is required to view this content. Sign in or start your free trial.

In This Article

  • Summary
  • Abstract
  • Introduction
  • Protocol
  • Representative Results
  • Discussion
  • Disclosures
  • Acknowledgements
  • Materials
  • References
  • Reprints and Permissions

Summary

This protocol introduces a method to develop a scaffold using decellularized rat kidneys. The protocol includes decellularization and recellularization processes to confirm bioavailability. Decellularization is performed using Triton X-100 and sodium dodecyl sulfate.

Abstract

Tissue engineering is a cutting-edge discipline in biomedicine. Cell culture techniques can be applied for regeneration of functional tissues and organs to replace diseased or damaged organs. Scaffolds are needed to facilitate the generation of three-dimensional organs or tissues using differentiated stem cells in vivo. In this report, we describe a novel method for developing vascularized scaffolds using decellularized rat kidneys. Eight-week-old Sprague-Dawley rats were used in this study, and heparin was injected into the heart to facilitate flow into the renal vessels, allowing heparin to perfuse into the renal vessels. The abdominal cavity was opened, and the left kidney was collected. The collected kidneys were perfused for 9 h using detergents, such as Triton X-100 and sodium dodecyl sulfate, to decellularize the tissue. Decellularized kidney scaffolds were then gently washed with 1% penicillin/streptomycin and heparin to remove cellular debris and chemical residues. Transplantation of stem cells with the decellularized vascular scaffolds is expected to facilitate the generation of new organs. Thus, the vascularized scaffolds may provide a foundation for tissue engineering of organ grafts in the future.

Introduction

Cell culture techniques are applied for regeneration of functional tissues and organs to replace diseased or damaged organs. Allogenic organ transplantation is currently the most common treatment for irreversible organ damage; however, this approach requires the use of immunosuppression to prevent rejection of the transplanted organ. Moreover, despite advances in transplant immunology, 20% of transplant recipients may experience acute rejection within 5 years, and within 10 years after transplantation, 40% of recipients may lose their transplanted graft or die1.

Advances in tissue engineering technologies have yielde....

Protocol

This study was approved by the administration of Pusan National University of Medicine and was conducted in accordance with ethical guidelines for the use and care of animals. (certificate no. 2017-119). Prior to any animal studies, institutional approval should be obtained.
NOTE: All surgical and anesthetic instruments/equipment and reagents recommended for successful surgical presentation and imaging of abdominal organs are detailed in Table 1.

1. Preparation procedures for harvesting of rat kidneys

  1. In preparation for surgery, place 8-week-old Sprague-Dawley rats (weighing 200–250 g) on a warming p....

Representative Results

The gross morphology of rat kidneys was dark red (Figure 1A). After decellularization, the kidney became pale and translucent (Figure 1D). Residual genomic DNA was assessed with a commercial kit according to the manufacturer’s instructions, in decellularized kidney scaffolds and compared with that in native kidneys (control). Quantitative analysis confirmed that tissue genomic DNA was almost eliminated after decellularization. From 14 cases, the average DN.......

Discussion

Various protocols have been used for decellularization of organs and other tissues. The optimal decellularization protocol should preserve the three-dimensional architecture of the extracellular matrix (ECM). In general, such protocols consist of lysing the cell membrane by physical processing or ionic solutions, dissociating the cytoplasm and nucleus from the ECM by enzymatic processing or detergents, and then removing cellular debris from the tissue3. Physical processes include scraping, solutio.......

Disclosures

The authors have no conflicts of interest to disclose.

Acknowledgements

This study was supported by a Biomedical Research Institute Grant from Pusan National University Hospital.

....

Materials

NameCompanyCatalog NumberComments
1 cc syringe (inject probes and vehicle solutionsBecton Dickinson305217
10-0 ethilon for vessel anastomosisEthicon9032G
25 gauge inch guide needle(for vascular catheters)Becton Dickinson305145
3-0 PDS incision closure ratEthiconZ316H
3-0 Prolene incision closure ratEthicon8832H
3-0 silk spool vascular access/ligation in ratBraintree ScientificSUT-S 110
4-0 PDS incision closure mouseEthiconZ773D
4-0 Prolene incision closure mouseEthicon8831H
5-0 silk spool vascular access/ligation in mouseBraintree ScientificSUT-S 106
Fine Scissors to cut fascia/connective tissueFine Science Tools14058-09
Halsey needle holderFine Science Tools12001-13
Kelly Hemostat for rats: muscle clamp to minimize bleeding when cutFine Science Tools13018-14
Polyethelyne 50 tubing, catheter tubing 100 ftBraintree Scientific.023" × .038”
Schwartz microserrefine vascular clampsFine Science Tools18052-01 (straight)
18052-03 (curved)
Surgical Scissors to cut skinFine Science Tools14002-12
Vannas-Tubingen Spring scissors for arteriotomyFine Science Tools15003-08

References

  1. Kawai, T., et al. Brief report: HLA-mismatched renal transplantation without maintenance immunosuppression. New England Journal of Medicine. 358 (4), 353-361 (2008).
  2. Rana, D., Zreiqat, H., Benkirane-Jessel, N., Ramakrishna, S., Ramalingam, M.

Reprints and Permissions

Request permission to reuse the text or figures of this JoVE article

Request Permission

Explore More Articles

DecellularizationKidney ScaffoldVascularized ScaffoldStem Cell DifferentiationTransplantation MedicineTissue EngineeringSprague Dawley RatPerfusionPBSHeparinPFAAbdominal AortaInferior Vena CavaKidney Harvest

This article has been published

Video Coming Soon

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2025 MyJoVE Corporation. All rights reserved